Advisor Group Holdings, Inc. Geron Corp Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Geron Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 87,954 shares of GERN stock, worth $121,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,954

Previous 120,429 26.97%

Holding current value

$121,376

Previous $169,000 26.63%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	SELL	$1.18 - $1.62 $38,320 - $52,609	-32,475 Reduced 26.97%	87,954 $124,000
Q2 2025 Aug 13, 2025	BUY	$1.18 - $1.62 $13,304 - $18,265	11,275 Added 10.33%	120,429 $169,000
Q1 2025 May 12, 2025	SELL	$1.59 - $3.6 $139,225 - $315,226	-87,563 Reduced 44.51%	109,154 $173,000
Q4 2024 Jun 06, 2025	BUY	$3.3 - $4.44 $338,167 - $454,989	102,475 Added 93.88%	211,629 $749,000
Q4 2024 Feb 07, 2025	BUY	$3.3 - $4.44 $16,170 - $21,756	4,900 Added 2.55%	196,717 $696,000
Q3 2024 Nov 13, 2024	BUY	$4.17 - $4.99 $9,461 - $11,322	2,269 Added 1.2%	191,817 $870,000
Q2 2024 Aug 13, 2024	SELL	$3.1 - $5.09 $243,827 - $400,348	-78,654 Reduced 29.33%	189,548 $803,000
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $71,743 - $141,026	40,996 Added 18.04%	268,202 $885,000
Q4 2023 Feb 12, 2024	SELL	$1.74 - $2.31 $125,226 - $166,248	-71,969 Reduced 24.06%	227,206 $479,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $154,996 - $240,942	73,458 Added 32.54%	299,175 $634,000
Q2 2023 Aug 21, 2023	SELL	$1.97 - $3.69 $1,759 - $3,295	-893 Reduced 0.39%	225,717 $724,000
Q2 2023 Aug 10, 2023	BUY	$1.97 - $3.69 $15,352 - $28,756	7,793 Added 3.56%	226,610 $727,000
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $20,768 - $32,997	9,705 Added 4.64%	218,817 $474,000
Q4 2022 Feb 10, 2023	BUY	$2.03 - $2.42 $10,003 - $11,925	4,928 Added 2.41%	209,112 $506,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $23,555 - $41,468	14,105 Added 7.42%	204,184 $478,000
Q2 2022 Aug 10, 2022	BUY	$1.19 - $1.65 $24,990 - $34,650	21,000 Added 12.42%	190,079 $296,000
Q1 2022 May 04, 2022	SELL	$0.99 - $1.6 $5,940 - $9,600	-6,000 Reduced 3.43%	169,079 $230,000
Q3 2021 Nov 05, 2021	BUY	$1.2 - $1.5 $13,176 - $16,470	10,980 Added 6.69%	175,079 $240,000
Q2 2021 Aug 02, 2021	BUY	$1.25 - $1.83 $87,515 - $128,121	70,012 Added 74.41%	164,099 $231,000
Q1 2021 May 13, 2021	SELL	$1.52 - $2.1 $2,368 - $3,271	-1,558 Reduced 1.63%	94,087 $149,000
Q4 2020 Feb 10, 2021	BUY	$1.55 - $2.05 $2,244 - $2,968	1,448 Added 1.54%	95,645 $153,000
Q3 2020 Nov 12, 2020	BUY	$1.59 - $2.19 $14,416 - $19,856	9,067 Added 10.65%	94,197 $164,000
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $13,765 - $28,579	13,110 Added 18.2%	85,130 $186,000
Q1 2020 May 18, 2020	BUY	$0.89 - $1.49 $64,097 - $107,309	72,020 New	72,020 $84,000

Others Institutions Holding GERN

# of Institutions

282

Shares Held

509M

Call Options Held

884K

Put Options Held

564K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $521M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Geron Corp Transaction History